Navigation Links
Onyx Pharmaceuticals Provides Update on Carfilzomib at 53rd American Society of Hematology Annual Meeting
Date:12/10/2011

cluded that these data confirm and extend earlier results indicating that single-agent carfilzomib has an acceptable safety profile in heavily pretreated patients with relapsed and refractory multiple myeloma. Carfilzomib was associated with a low rate of typically mild to moderate, non dose-limiting peripheral neuropathy (PN). PN of any grade was reported in 73 patients (14 percent) across the studies, and one patient (<1 percent) discontinued treatment due to a PN-related adverse event. In regard to renal events, less than 1 percent of patients discontinued treatment due to a renal event and 87 percent of patients had no worsening of renal function. Investigator-assessed cardiac events, some of which resulted in death possibly related to carfilzomib (<1 percent) or treatment discontinuation, were reported in this heavily pretreated, late-stage population. Cardiac failure events were reported in 7 percent of patients regardless of causality. Cardiac events resulting in treatment discontinuation included congestive heart failure (2 percent), cardiac arrest (1 percent) and myocardial ischemia (<1 percent). The extent to which cardiac events were due to patients' baseline comorbidities, toxicity from prior treatments, effects of multiple myeloma, carfilzomib itself, or a combination of these factors could not be determined. Rates and causes of death were consistent with those observed in heavily pretreated patients with end-stage multiple myeloma.

Abstract #1875: Unfavorable Cytogenetic Characteristics do not Adversely Impact Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Single-Agent Carfilzomib on the 003-A1 Study
This analysis evaluated the impact of specific cytogenetic abnormalities on efficacy and treatment outcomes including response rates, time-to-event endpoints, and OS. In patients with multiple myeloma, cytogenetic abnormalities with certain genetic variations have a well-documente
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Radient Pharmaceuticals Submits an Abstract to the American Society of Colon and Rectal Surgeons
2. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
3. Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Additions to its Development Pipeline
4. Survival Benefit With Syndax Pharmaceuticals Entinostat Maintained in Women with Advanced Breast Cancer
5. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
6. Inovio Pharmaceuticals Closes $4.0 Million Underwritten Financing
7. Onyx Pharmaceuticals to Host a Teleconference to Reprise Key Data From the American Society of Hematology Meeting
8. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
9. Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer
10. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
11. Radient Pharmaceuticals Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015  Astellas today announced topline results from ... and safety of intravenous (IV) and oral isavuconazole, ... for adults with candidemia and other invasive ... that the trial did not meet its primary ... isavuconazole-treated patients at the end of IV therapy ...
(Date:7/29/2015)... Mass. , July 29, 2015 Insulet Corporation ... pump technology with its OmniPod ® Insulin Management ... months ended June 30, 2015. The Company also announced ... second quarter financial results and conference call from Thursday, ... Preliminary Second Quarter Revenue Highlights: ...
(Date:7/29/2015)... 29, 2015  UBM Canon brings MEDevice San Diego ... & Marina on September 1-2, 2015, with a multi-track ... of the Business Development track will be a panel ... of Investors, featuring Renee Ryan , Vice President ... Brent Ahrens , Partner, Canaan Partners; and Jordan ...
Breaking Medicine Technology:Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5MEDevice San Diego Offers Tips on Securing Financial Backing from Investors 2
... 2011 IOD Incorporated, a leading provider of integrated ... today announced it has received the federal ... Meaningful Use certification of its PRISM platform for both ... deems the software capable of enabling providers to qualify ...
... Arecor Limited has entered into ... to assess Arecor,s advanced protein formulation technologies for ... drugs.  Under this agreement, Arecor will develop stable ... and peptide drug candidates developed by Lilly.  In addition, ...
Cached Medicine Technology:IOD Incorporated's PRISM™ Receives ONC-ATCB Certification by Drummond Group 2IOD Incorporated's PRISM™ Receives ONC-ATCB Certification by Drummond Group 3Arecor Forms Collaboration With Lilly to Develop Advanced Formulations of Protein Therapeutics 2
(Date:7/30/2015)... ... July 30, 2015 , ... Ross A. Clevens, ... of Medicine as Assistant Professor of Plastic Surgery. This is Dr. Clevens’ second ... worked closely with the university, developing a strong presence and a valuable mentoring program ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Using the ... suicide and teach people more effective ways to prevent and manage major depression. , ... react fast enough, so people fall through the cracks and die needlessly everyday,” says ...
(Date:7/30/2015)... ... July 30, 2015 , ... Between 2012 and 2014 ... Health News Florida on June 17th. Those untreated heroin use disorders share ... prevent the spread of dirty needles throughout the community. Ultimately Florida’s HIV infection rates ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association of ... announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th event ... AM to 2:00 PM local time. On the 26th, the DEA, with the ...
(Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading ... designed a personal-care device that makes it easy to apply lotion or medication to ... need for assistance when applying lotion or medication to the back, and provides thorough ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... , SACRAMENTO, Calif., Dec. 17 Just in time for ... tighten their firm grip on drunk drivers today by and declaring ... $8 million in grant funding to 148 law enforcement agencies for ... California Office of Traffic Safety (OTS) will fund more than 2,500 ...
... , , Some of NYC,s most iconic ... oil phase out by 2020 , http://www.edf.org/dirtybuildings , ... pollution is created by burning the dirtiest heating oils available in only one ... report released today by Environmental Defense Fund . As a ...
... , , , ... Alliance for,Improved Nutrition released today its 2008-2009 Annual Report. ... malnutrition in,high-burden countries. GAIN,s national food fortification projects are,reaching ... million,women and young children. "Our attention to measuring the ...
... ... General Hospital project that used a novel communication tool to improve health outcomes among ... Care Safety Net Institute. , ... (Vocus) December 17, 2009 -- A UCSF/San Francisco General Hospital project that ...
... ... her options for birth – capturing all her wishes and preferences in a birth plan ... she wants. Her birth plan does not match her provider’s practice style. , ... Silver Spring, MD (Vocus) December 17, 2009 ...
... ... funding needed for continued success , ... Washington, DC (PRWEB) December 17, 2009 -- According to the World Health ... third of affected countries included in the study have witnessed reduction in malaria cases by ...
Cached Medicine News:Health News:California Announces 2010 as The Year of the Checkpoint 2Health News:California Announces 2010 as The Year of the Checkpoint 3Health News:9,000 NYC Buildings Burning Dirty Heating Oil Identified in New Report 2Health News:9,000 NYC Buildings Burning Dirty Heating Oil Identified in New Report 3Health News:9,000 NYC Buildings Burning Dirty Heating Oil Identified in New Report 4Health News:GAIN's Effectiveness in Reducing Malnutrition Confirmed in its New Annual Report 2Health News:SFGH Project for Diabetes Patients Wins Award for Innovation, Quality 2Health News:SFGH Project for Diabetes Patients Wins Award for Innovation, Quality 3Health News:Who Should Deliver Your Baby? New Tool Helps Expectant Parents Choose Their Health Care Provider 2Health News:Who Should Deliver Your Baby? New Tool Helps Expectant Parents Choose Their Health Care Provider 3Health News:WHO World Malaria Report Shows Aid Efforts Are Working 2Health News:WHO World Malaria Report Shows Aid Efforts Are Working 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: